You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華熙生物(688363.SH)業績快報:2020年度淨利潤升10.5%至6.47億元
格隆匯 02-25 18:31

格隆匯 2 月 25日丨華熙生物(688363.SH)發佈2020年度業績快報,實現營業收入26.32億元,同比增加39.61%;歸屬於母公司所有者的淨利潤6.47億元,同比增加10.50%;歸屬於母公司所有者的扣除非經常性損益的淨利潤5.7億元,同比增加0.47%;基本每股收益1.35元。

營業收入同比增長39.61%,主要原因是功能性護膚品銷售收入較上年同期大幅增長,同時醫療終端產品銷售收入實現小幅增長

報吿期內,全球疫情影響原料業務收入上年同期略有下降。公司終端產品市場開發力度豐富終端產品銷售渠道,進一步提升品牌知名度及端產品市場佔有率功能性護膚品銷售收入較上年大幅增長,醫療終端產品銷售收入在疫情影響下仍實現小幅增長

目前公司功能性護膚品業務處於戰略機遇期,為實現構建國民品牌,打造長期持續較快速度增長的基礎,2020年公司品牌建設、渠道構建、關鍵人才引進等戰略性投入較大;同時公司也在持續加大中後台支持能力建設供應鏈體系的投入等,因此公司2020年度營業收入實現快速增長,營業利潤較上年同期略有增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account